{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T10:20:00Z","timestamp":1791368400449,"version":"4.3.1"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2023,4,1]]},"abstract":"Importance<\/jats:title>Sexual orientation and gender identity data are not collected by most hospitals or cancer registries; thus, little is known about the quality of breast cancer treatment for patients from sex and gender minority (SGM) groups.<\/jats:p><\/jats:sec>Objective<\/jats:title>To evaluate the quality of breast cancer treatment and recurrence outcomes for patients from SGM groups compared with cisgender heterosexual patients.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>Exposure-matched retrospective case-control study of 92 patients from SGM groups treated at an academic medical center from January 1, 2008, to January 1, 2022, matched to cisgender heterosexual patients with breast cancer by year of diagnosis, age, tumor stage, estrogen receptor status, and ERBB2 (HER2) status.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Patient demographic and clinical characteristics, as well as treatment quality, as measured by missed guideline-based breast cancer screening, appropriate referral for genetic counseling and testing, mastectomy vs lumpectomy, receipt of chest reconstruction, adjuvant radiation therapy after lumpectomy, neoadjuvant chemotherapy for stage III disease, antiestrogen therapy for at least 5 years for estrogen receptor\u2013positive disease, ERBB2-directed therapy for ERBB2-positive disease, patient refusal of an oncologist-recommended treatment, time from symptom onset to tissue diagnosis, time from diagnosis to first treatment, and time from breast cancer diagnosis to first recurrence. Results were adjusted for multiple hypothesis testing. Compared with cisgender heterosexual patients, those from SGM groups were hypothesized to have disparities in 1 or more of these quality metrics.<\/jats:p><\/jats:sec>Results<\/jats:title>Ninety-two patients from SGM groups were matched to 92 cisgender heterosexual patients (n\u2009=\u2009184). The median age at diagnosis for all patients was 49 years (IQR, 43-56 years); 74 were lesbian (80%), 12 were bisexual (13%), and 6 were transgender (6%). Compared with cisgender heterosexual patients, those from SGM groups experienced a delay in time from symptom onset to diagnosis (median time to diagnosis, 34 vs 64 days; multivariable adjusted hazard ratio, 0.65; 95% CI, 0.42-0.99; P<\/jats:italic>\u2009=\u2009.04), were more likely to decline an oncologist-recommended treatment modality (35 [38%] vs 18 [20%]; multivariable adjusted odds ratio, 2.27; 95% CI, 1.09-4.74; P<\/jats:italic>\u2009=\u2009.03), and were more likely to experience a breast cancer recurrence (multivariable adjusted hazard ratio, 3.07; 95% CI, 1.56-6.03; P<\/jats:italic>\u2009=\u2009.001).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>This study found that among patients with breast cancer, those from SGM groups experienced delayed diagnosis, with faster recurrence at a 3-fold higher rate compared with cisgender heterosexual patients. These results suggest disparities in the care of patients from SGM groups and warrant further study to inform interventions.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaoncol.2022.7146","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T16:08:15Z","timestamp":1675354095000},"page":"473","source":"Crossref","is-referenced-by-count":58,"title":["Breast Cancer Diagnosis, Treatment, and Outcomes of Patients From Sex and Gender Minority Groups"],"prefix":"10.1001","volume":"9","author":[{"given":"Erik","family":"Eckhert","sequence":"first","affiliation":[{"name":"Department of Medicine, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Lansinger","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Ritter","sequence":"additional","affiliation":[{"name":"Qualitatitive Statistical Unit, Department of Medicine, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Summer","family":"Han","sequence":"additional","affiliation":[{"name":"Qualitatitive Statistical Unit, Department of Medicine, Stanford University School of Medicine, Stanford, California"},{"name":"Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Schapira","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther M.","family":"John","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University School of Medicine, Stanford, California"},{"name":"Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scarlett","family":"Gomez","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Sledge","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison W.","family":"Kurian","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University School of Medicine, Stanford, California"},{"name":"Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"coi220092r1","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/cncr.31925","article-title":"Acquisition of sexual orientation and gender identity data among NCI Community Oncology Research Program practice groups.","volume":"125","author":"Cathcart-Rake","year":"2019","journal-title":"Cancer"},{"key":"coi220092r2","doi-asserted-by":"publisher","author":"Kamen","journal-title":"JCO Oncol Pract","DOI":"10.1200\/OP.22.00084"},{"issue":"7","key":"coi220092r3","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1200\/JCO.18.00551","article-title":"National Survey of Oncologists at National Cancer Institute\u2013designated comprehensive cancer centers: attitudes, knowledge, and practice behaviors about LGBTQ patients with cancer.","volume":"37","author":"Schabath","year":"2019","journal-title":"J Clin Oncol"},{"issue":"2","key":"coi220092r4","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.2105\/AJPH.2013.301501","article-title":"Research funded by the National Institutes of Health on the health of lesbian, gay, bisexual, and transgender populations.","volume":"104","author":"Coulter","year":"2014","journal-title":"Am J Public Health"},{"issue":"8","key":"coi220092r5","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Physicians don\u2019t ask, sometimes patients tell: disclosure of sexual orientation among women with breast carcinoma.","volume":"101","author":"Boehmer","year":"2004","journal-title":"Cancer"},{"issue":"4","key":"coi220092r6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.whi.2015.03.014","article-title":"Breast cancer risk in sexual minority women during routine screening at an urban LGBT health center.","volume":"25","author":"Clavelle","year":"2015","journal-title":"Womens Health Issues"},{"issue":"2","key":"coi220092r7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1089\/lgbt.2019.0274","article-title":"Breast cancer risk, screening, and prevalence among sexual minority women: an analysis of the National Health Interview Survey.","volume":"7","author":"Williams","year":"2020","journal-title":"LGBT Health"},{"issue":"1","key":"coi220092r8","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1186\/1471-2458-13-1127","article-title":"Breast cancer in lesbians and bisexual women: systematic review of incidence, prevalence and risk studies.","volume":"13","author":"Meads","year":"2013","journal-title":"BMC Public Health"},{"issue":"3","key":"coi220092r9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004461","article-title":"Sexual minority population density and incidence of lung, colorectal and female breast cancer in California.","volume":"4","author":"Boehmer","year":"2014","journal-title":"BMJ Open"},{"issue":"5","key":"coi220092r10","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1055\/s-0037-1606103","article-title":"Breast cancer screening, management, and a review of case study literature in transgender populations.","volume":"35","author":"Deutsch","year":"2017","journal-title":"Semin Reprod Med"},{"key":"coi220092r11","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djab028","author":"Jackson","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"coi220092r12","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1089\/lgbt.2014.0119","article-title":"Comparison of lesbian and bisexual women to heterosexual women\u2019s screening prevalence for breast, cervical, and colorectal cancer in Missouri.","volume":"2","author":"McElroy","year":"2015","journal-title":"LGBT Health"},{"issue":"6","key":"coi220092r13","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1089\/lgbt.2020.0039","article-title":"Sexual orientation identity disparities in mammography among White, Black, and Latina US women.","volume":"7","author":"Ag\u00e9nor","year":"2020","journal-title":"LGBT Health"},{"issue":"6","key":"coi220092r14","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/pon.v27.6","article-title":"Experiences and unmet needs of lesbian, gay, and bisexual people with cancer care: a systematic review and meta-synthesis.","volume":"27","author":"Lisy","year":"2018","journal-title":"Psychooncology"},{"issue":"1","key":"coi220092r15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s13643-021-01707-4","article-title":"Health outcomes of sexual and gender minorities after cancer: a systematic review.","volume":"10","author":"Pratt-Chapman","year":"2021","journal-title":"Syst Rev"},{"issue":"2","key":"coi220092r16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1300\/J013v44n02_03","article-title":"Sexual minority women\u2019s interactions with breast cancer providers.","volume":"44","author":"Boehmer","year":"2006","journal-title":"Women Health"},{"issue":"24","key":"coi220092r17","doi-asserted-by":"publisher","first-page":"4371","DOI":"10.1002\/cncr.v125.24","article-title":"Care delivery, patient experiences, and health outcomes among sexual and gender minority patients with cancer and survivors: a scoping review.","volume":"125","author":"Kent","year":"2019","journal-title":"Cancer"},{"issue":"1","key":"coi220092r19","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.5671","article-title":"Clinical characteristics, experiences, and outcomes of transgender patients with cancer.","volume":"7","author":"Burns","year":"2021","journal-title":"JAMA Oncol"},{"issue":"1","key":"coi220092r21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/cncr.28395","article-title":"Breast cancer treatment across health care systems: linking electronic medical records and state registry data to enable outcomes research.","volume":"120","author":"Kurian","year":"2014","journal-title":"Cancer"},{"issue":"12","key":"coi220092r22","doi-asserted-by":"publisher","first-page":"e1837","DOI":"10.1200\/OP.20.01093","article-title":"Limited English proficiency and disparities in health care engagement among patients with breast cancer.","volume":"17","author":"Roy","year":"2021","journal-title":"JCO Oncol Pract"},{"issue":"10","key":"coi220092r23","doi-asserted-by":"publisher","first-page":"e1403","DOI":"10.1200\/OP.20.00462","article-title":"Benchmark method for cost computations across health care systems: cost of care per patient per day in breast cancer care.","volume":"17","author":"Blayney","year":"2021","journal-title":"JCO Oncol Pract"},{"issue":"5","key":"coi220092r24","doi-asserted-by":"publisher","first-page":"484","DOI":"10.6004\/jnccn.2021.0023","article-title":"NCCN Guidelines\u00ae insights: breast cancer, version 4.2021.","volume":"19","author":"Gradishar","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"coi220092r25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN Clinical Practice Guidelines in Oncology.","volume":"19","author":"Daly","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"11","key":"coi220092r26","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.6004\/jnccn.2018.0083","article-title":"Breast cancer screening and diagnosis, version 3.2018, NCCN Clinical Practice Guidelines in Oncology.","volume":"16","author":"Bevers","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"issue":"25","key":"coi220092r27","doi-asserted-by":"publisher","first-page":"6233","DOI":"10.1200\/JCO.2005.05.948","article-title":"A process for measuring the quality of cancer care: the Quality Oncology Practice Initiative.","volume":"23","author":"Neuss","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"coi220092r29","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/rssb.1995.57.issue-1","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing.","volume":"57","author":"Benjamini","year":"1995","journal-title":"J Royal Stat Soc Ser B Methodol"},{"issue":"7","key":"coi220092r31","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/jamia\/ocy022","article-title":"Using clinician text notes in electronic medical record data to validate transgender-related diagnosis codes.","volume":"25","author":"Blosnich","year":"2018","journal-title":"J Am Med Inform Assoc"},{"issue":"2","key":"coi220092r32","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s13178-019-00398-w","article-title":"The MSM (non)identity: toward understanding sexual behavior and identity in health research and practice with straight men under the umbrella.","volume":"17","author":"Zeglin","year":"2020","journal-title":"Sex Res Soc Policy"},{"issue":"1","key":"coi220092r33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1089\/jwh.2008.1094","article-title":"Risk factors for reproductive and breast cancers among older lesbians.","volume":"19","author":"Zaritsky","year":"2010","journal-title":"J Womens Health (Larchmt)"},{"issue":"7","key":"coi220092r34","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1007\/s00520-018-4535-0","article-title":"\u201cTreat us with dignity\u201d: a qualitative study of the experiences and recommendations of lesbian, gay, bisexual, transgender, and queer (LGBTQ) patients with cancer.","volume":"27","author":"Kamen","year":"2019","journal-title":"Support Care Cancer"},{"issue":"10","key":"coi220092r36","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1080\/00918369.2011.614902","article-title":"Lesbian, gay, bisexual, and transgender (LGBT) physicians\u2019 experiences in the workplace.","volume":"58","author":"Eliason","year":"2011","journal-title":"J Homosex"},{"issue":"6","key":"coi220092r37","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.whi.2014.08.003","article-title":"Addressing health disparities of lesbian and bisexual women: a grounded theory study.","volume":"24","author":"Johnson","year":"2014","journal-title":"Womens Health Issues"},{"issue":"10","key":"coi220092r38","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1001\/jamaoncol.2018.2487","article-title":"Complementary medicine, refusal of conventional cancer therapy, and survival among patients with curable cancers.","volume":"4","author":"Johnson","year":"2018","journal-title":"JAMA Oncol"},{"issue":"12","key":"coi220092r39","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1089\/jwh.2018.7127","article-title":"Breast cancer screening and care among Black sexual minority women: a scoping review of the literature from 1990 to 2017.","volume":"28","author":"Malone","year":"2019","journal-title":"J Womens Health (Larchmt)"},{"key":"coi220092r18","volume-title":"Understanding the Well-Being of LGBTQI+ Populations","year":"2020"},{"key":"coi220092r20","unstructured":"Weber? S, Seto? T, Olson? C, Kenkare? P, Kurian? A, Das? A. Oncoshare: lessons learned from building an integrated multi-institutional database for comparative effectiveness research. AMIA Annu Symp Proc. 2012;2012:970-978. 23304372"},{"key":"coi220092r28","unstructured":"San Francisco School of Medicine Dean\u2019s Office of Population Health and Health Equity. UCSF health atlas. Published 2022. Accessed January 15, 2022. https:\/\/www.healthatlas.ucsf.edu\/?active=nSES_quintile&geography=counties"},{"key":"coi220092r30","unstructured":"US Department of Health and Human Services. Helping patients who drink too much: a clinician\u2019s guide. Accessed June 17, 2022. https:\/\/pubs.niaaa.nih.gov\/publications\/Practitioner\/CliniciansGuide2005\/guide.pdf"},{"key":"coi220092r35","unstructured":"Herman? J, Rankin? S, Keisling? M, Mottet? L, Anafi? M. The report of the 2015 Transgender Survey: executive summary. National Center for Transgender Equality. Published December 2016. Updated December 2017. Accessed June 1, 2022. https:\/\/transequality.org\/sites\/default\/files\/docs\/usts\/USTS-Executive-Summary-Dec17.pdf"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2800989\/jamaoncology_eckhert_2023_oi_220092_1681755674.69147.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T16:42:52Z","timestamp":1682008972000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2800989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,1]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2022.7146","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,1]]}}}